Osaic Holdings
TXMD icon

Osaic Holdings’s TherapeuticsMD TXMD Stock Holding History

Osaic Holdings’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.6K Buy
15,198
+15,045
+9,833% +$31.1K ﹤0.01% 5775
2026
Q1 		$308 Sell
153
-9,144
-98% -$20.6K ﹤0.01% 7509
2025
Q4 		$15.2K Buy
9,297
+8,400
+936% +$12.1K ﹤0.01% 6050
2025
Q3 		$972 Buy
897
+36
+4% +$40 ﹤0.01% 7367
2025
Q2 		$982 Buy
861
+11
+1% +$13 ﹤0.01% 7152
2025
Q1 		$788 Buy
850
+830
+4,150% +$827 ﹤0.01% 6889
2024
Q4 		$17 Sell
20
-36
-64% -$51 ﹤0.01% 7333
2024
Q3 		$92 Hold
56
– – ﹤0.01% 7253
2024
Q2 		$90 Sell
56
-980
-95% -$1.98K ﹤0.01% 7259
2024
Q1 		$2.37K Buy
1,036
+1,000
+2,778% +$2.31K ﹤0.01% 6407
2023
Q4 		$81 Sell
36
-215
-86% -$519 ﹤0.01% 7131
2023
Q3 		$756 Sell
251
-3,286
-93% -$12.4K ﹤0.01% 6906
2023
Q2 		$14.6K Buy
3,537
+3,020
+584% +$11.8K ﹤0.01% 5756
2023
Q1 		$1.94K Hold
517
– – ﹤0.01% 6725
2022
Q4 		$3.11K Buy
517
+15
+3% +$88 ﹤0.01% 6468
2022
Q3 		$4K Buy
502
+75
+18% +$607 ﹤0.01% 6525
2022
Q2 		$4K Sell
427
-92
-18% -$879 ﹤0.01% 6634
2022
Q1 		$1.76M Sell
519
-6
-1% -$94 ﹤0.01% 2031
2021
Q4 		$9K Sell
525
-60
-10% -$1.8K ﹤0.01% 6354
2021
Q3 		$20K Buy
585
+360
+160% +$16K ﹤0.01% 5782
2021
Q2 		$13K Sell
225
-1
-0.4% -$61 ﹤0.01% 5919
2021
Q1 		$15K Buy
226
+9
+4% +$705 ﹤0.01% 5659
2020
Q4 		$13K Sell
217
-405
-65% -$27.7K ﹤0.01% 5412
2020
Q3 		$49K Buy
622
+74
+14% +$5.9K ﹤0.01% 4320
2020
Q2 		$33K Sell
548
-561
-51% -$32.7K ﹤0.01% 4477
2020
Q1 		$59K Buy
+1,109
New +$110K ﹤0.01% 3866

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Osaic Holdings's TXMD Position: Q2 2026 in Review

Osaic Holdings increased its TherapeuticsMD (TXMD) stake by 9,833% in Q2 2026, buying an estimated $31.1K and bringing the position to 15,198 shares worth $33.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5775.

Osaic Holdings first reported a position in TXMD in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.76M in Q1 2022. 44 funds tracked by Wall St. Rank hold TXMD as of Q2 2026.

  • Osaic Holdings held 15,198 shares of TherapeuticsMD worth $33.6K as of Q2 2026.
  • Osaic Holdings bought 15,045 TherapeuticsMD shares in Q2 2026, an estimated $31.1K.
  • TherapeuticsMD made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5775 holding.
  • Osaic Holdings first reported a position in TherapeuticsMD in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's TherapeuticsMD position peaked at $1.76M in Q1 2022.
  • 44 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.